Nuveen, LLC Nurix Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 169,145 shares of NRIX stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,145Holding current value
$1.85 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NRIX
# of Institutions
188Shares Held
67.2MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$74.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$48.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$45.9 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$42.5 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$34.9 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $516M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...